Successfully addressing the global antimicrobial resistance (AMR) crisis requires a creative, strategic, and multifaceted approach. As a world-leading institution in AMR research and innovation, McMaster University is leveraging its impact through the David Braley Centre for Antibiotic Discovery.

Through the generous support of dedicated donors, partners, and governments, this Centre of Excellence will provide McMaster’s team of distinguished scientists with the opportunity to translate new knowledge into real impact. ​

Building on McMaster University’s strengths, resources, and partnerships, researchers at the David Braley Centre for Antibiotic Discovery are equipped to lead in international efforts against AMR. Our assets include:

• ​ A world-class team of scientists and clinicians, who specialize in all levels of AMR research ​
• An impeccable track record of successful and innovative AMR research, publications and developments An expansive multi-user laboratory, which includes Canada’s first antimicrobial drug discovery facility and largest university-based compound library
• A newly-renovated BSL3 containment lab for the study of deadly human pathogens
• A variety of animal models of infection for the testing of antibiotics and antibiotic alternatives
• Platforms for the testing of hundreds of drug-resistant bacteria retrieved from clinical samples across the globe
• Unique bioinformatic tools and big data platforms, such as the Comprehensive Antibiotic Resistance Database (CARD) – a tool used daily by scientists worldwide
• A long-standing and globally recognized capacity for clinical trials at all stages.